Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 176983, 10 pages
http://dx.doi.org/10.1155/2015/176983
Research Article

Loss of AMP-Activated Protein Kinase Induces Mitochondrial Dysfunction and Proinflammatory Response in Unstimulated Abcd1-Knockout Mice Mixed Glial Cells

Department of Neurology, Henry Ford Health System, Detroit, MI 48202, USA

Received 12 January 2015; Accepted 18 February 2015

Academic Editor: Luc Vallières

Copyright © 2015 Jaspreet Singh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kemp, J. Berger, and P. Aubourg, “X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects,” Biochimica et Biophysica Acta, vol. 1822, no. 9, pp. 1465–1474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Contreras, J. Mosser, J. L. Mandel, P. Aubourg, and I. Singh, “The protein coded by the X-adenoleukodystrophy gene is a peroxisomal integral membrane protein,” FEBS Letters, vol. 344, no. 2-3, pp. 211–215, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Engelen, S. Kemp, M. de Visser et al., “X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Singh and A. Pujol, “Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis,” Brain Pathology, vol. 20, no. 4, pp. 838–844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-F. Lu, A. M. Lawler, P. A. Watkins et al., “A mouse model for X-linked adrenoleukodystrophy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 17, pp. 9366–9371, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Kobayashi, N. Shinnoh, A. Kondo, and T. Yamada, “Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism,” Biochemical and Biophysical Research Communications, vol. 232, no. 3, pp. 631–636, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Forss-Petter, H. Werner, J. Berger et al., “Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice,” Journal of Neuroscience Research, vol. 50, no. 5, pp. 829–843, 1997. View at Publisher · View at Google Scholar
  8. A. Pujol, C. Hindelang, N. Callizot, U. Bartsch, M. Schachner, and J. L. Mandel, “Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy,” Human Molecular Genetics, vol. 11, no. 5, pp. 499–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Singh and S. Giri, “Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes,” Biochemical and Biophysical Research Communications, vol. 445, no. 1, pp. 126–131, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. C. Carroll, B. Viollet, and J. Suttles, “AMPKalpha1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling,” Journal of Leukocyte Biology, vol. 94, no. 6, pp. 1113–1121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Nath, M. Khan, R. Rattan et al., “Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity,” Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 16–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. A. J. O'Neill and D. Grahame Hardie, “Metabolism of inflammation limited by AMPK and pseudo-starvation,” Nature, vol. 493, no. 7432, pp. 346–355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Nath, M. Khan, M. K. Paintlia, I. Singh, M. N. Hoda, and S. Giri, “Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis,” The Journal of Immunology, vol. 182, pp. 8005–8014, 2009. View at Google Scholar
  14. N. Nath, S. Giri, R. Prasad, M. L. Salem, A. K. Singh, and I. Singh, “5-Aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis,” The Journal of Immunology, vol. 175, no. 1, pp. 566–574, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. H. M. O'Neill, S. J. Maarbjerg, J. D. Crane et al., “AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 38, pp. 16092–16097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Singh, M. Khan, and I. Singh, “Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy,” Journal of Lipid Research, vol. 50, no. 1, pp. 135–147, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Nath, M. Khan, R. Rattan et al., “Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity,” Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 16–20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Galic, M. D. Fullerton, J. D. Schertzer et al., “Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity,” Journal of Clinical Investigation, vol. 121, no. 12, pp. 4903–4915, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Mounier, M. Théret, L. Arnold et al., “AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration,” Cell Metabolism, vol. 18, no. 2, pp. 251–264, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Singh, M. Khan, A. Pujol, M. Baarine, and I. Singh, “Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells,” PLoS ONE, vol. 8, no. 7, Article ID e70712, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Fourcade, J. López-Erauskin, M. Ruiz, I. Ferrer, and A. Pujol, “Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy,” Biochimie, vol. 98, no. 1, pp. 143–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Berger, S. Forss-Petter, and F. S. Eichler, “Pathophysiology of X-linked adrenoleukodystrophy,” Biochimie, vol. 98, no. 1, pp. 135–142, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. De Meirleir, S. Seneca, W. Lissens et al., “Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12,” Journal of Medical Genetics, vol. 41, no. 2, pp. 120–124, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Zhu, X. Peng, M. X. Guan, and Q. Yan, “Pathogenic mutations of nuclear genes associated with mitochondrial disorders,” Acta Biochimica et Biophysica Sinica, vol. 41, no. 3, pp. 179–187, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. H. Triepels, L. P. van den Heuvel, J. L. C. M. Loeffen et al., “Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I,” Annals of Neurology, vol. 45, no. 6, pp. 787–790, 1999. View at Publisher · View at Google Scholar
  26. J. Smeitink and L. van den Heuvel, “Human mitochondrial complex I in health and disease,” The American Journal of Human Genetics, vol. 64, no. 6, pp. 1505–1510, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Bénit, D. Chretien, N. Kadhom et al., “Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency,” American Journal of Human Genetics, vol. 68, no. 6, pp. 1344–1352, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Bourgeron, P. Rustin, D. Chretien et al., “Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency,” Nature Genetics, vol. 11, no. 2, pp. 144–149, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. A. I. Jonckheere, G. Herma Renkema, M. Bras et al., “A complex v ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy,” Brain, vol. 136, no. 5, pp. 1544–1554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. P. J. Fernandez-Marcos and J. Auwerx, “Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis,” The American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 884S–890S, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. R. C. Scarpulla, “Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1269–1278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. M. B. de Moura and B. van Houten, “Bioenergetic analysis of intact mammalian cells using the seahorse XF24 extracellular flux analyzer and a luciferase ATP assay,” in Molecular Toxicology Protocols, vol. 1105 of Methods in Molecular Biology, pp. 589–602, Humana Press, 2014. View at Publisher · View at Google Scholar
  33. F. Reinecke, J. A. M. Smeitink, and F. H. van der Westhuizen, “OXPHOS gene expression and control in mitochondrial disorders,” Biochimica et Biophysica Acta, vol. 1792, no. 12, pp. 1113–1121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Matsukawa, M. Asheuer, Y. Takahashi et al., “Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes,” Neurogenetics, vol. 12, no. 1, pp. 41–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Viollet, Y. Athea, R. Mounier et al., “AMPK: lessons from transgenic and knockout animals,” Frontiers in Bioscience (Landmark Ed), vol. 14, no. 1, pp. 19–44, 2009. View at Publisher · View at Google Scholar · View at Scopus